Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Drug Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00033163
What this trial is testing

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableLooking for participantsNCT05633056
What this trial is testing

An Adaptive Randomized Controlled Trial

Who this might be right for
Multi Drug Resistant TuberculosisHIV Infections
Columbia University 360
Large-scale testing (Phase 3)WithdrawnNCT00686270
What this trial is testing

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Who this might be right for
HIV Infections
Avexa
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableEnded earlyNCT00193947
What this trial is testing

An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy

Who this might be right for
Drug Resistance
University Health Network, Toronto 56
Testing effectiveness (Phase 2)Study completedNCT00214890
What this trial is testing

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Who this might be right for
HIV Infections
University of California, San Diego 21
Testing effectiveness (Phase 2)Study completedNCT00460382
What this trial is testing

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 103
Not applicableStudy completedNCT06932796
What this trial is testing

Project Orleu: Reducing Intersectional and HIV Stigma Among Health Care Providers and High Risk Women Who Use Drugs in Kazakhstan

Who this might be right for
Stigma, Social
Columbia University 83
Not applicableUnknownNCT04593979
What this trial is testing

ANRS 12406 EvvA Study

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 289
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Not applicableStudy completedNCT00959088
What this trial is testing

Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 641
Not applicableStudy completedNCT00279331
What this trial is testing

Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador

Who this might be right for
HIV InfectionsSyphilisSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 2,608
Large-scale testing (Phase 3)Study completedNCT00002199
What this trial is testing

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Who this might be right for
HIV Infections
Glaxo Wellcome 550
Not applicableLooking for participantsNCT05373758
What this trial is testing

Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa

Who this might be right for
HIV InfectionsAIDSVirologic Failure
Massachusetts General Hospital 648
Not applicableUnknownNCT03557021
What this trial is testing

Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in Tanzania

Who this might be right for
HIV Drug Resistance
Medical Mission Institute, Germany 1,250
Large-scale testing (Phase 3)Study completedNCT00144170
What this trial is testing

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

Who this might be right for
HIV Infections
Boehringer Ingelheim 882
Large-scale testing (Phase 3)Study completedNCT00021554
What this trial is testing

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Large-scale testing (Phase 3)Study completedNCT00002220
What this trial is testing

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 120
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)UnknownNCT01230580
What this trial is testing

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Who this might be right for
HIV InfectionAcquired Immunodeficiency Syndrome
Medical Research Council 587
Next Page